News wire

Drugs and medical devices

Pharmaceuticals, implants and medical devices: safety communications, label changes, approvals and the litigation that follows them.

Source check 3 min ago · Newest item 9 hr ago · 1,441 stories this week · 86 of 90 publishers answering · Browse publishers · RSS feed

PI DATA HUBLegal intelligence
Filter stories (1)

Drugs and medical devices

Tuesday, October 13

Monday, October 12

Friday, October 9

Federal Register notice Federal Register: FDA

Medical Devices; Immunology and Microbiology Devices; Classification of the Hematopoietic Cell Enrichment Kit

The Food and Drug Administration (FDA) is classifying the hematopoietic cell enrichment kit into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the hematopoietic cell enrichment kit. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing…

Read at Federal Register: FDA

Federal Register notice Federal Register: FDA

Medical Devices; Cardiovascular Devices; Classification of the Infant Pulse Rate and Oxygen Saturation Monitor for Over-the-Counter Use

The Food and Drug Administration (FDA) is classifying the infant pulse rate and oxygen saturation monitor for over-the-counter use into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the infant pulse rate and oxygen saturation monitor for over-the-counter use. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also…

Read at Federal Register: FDA

Thursday, October 8

Connect the news to your market.

Research the firms, offices and conference relationships behind the headlines.

Request research access